Depleting hepatitis B virus relaxed circular DNA is necessary for resolution of infection by CRISPR-Cas9-Reference-Cited by-同舟云学术

Depleting hepatitis B virus relaxed circular DNA is necessary for resolution of infection by CRISPR-Cas9

Published:2023-03 Issue: Volume:31 Page:482-493
ISSN:2162-2531
Container-title:Molecular Therapy - Nucleic Acids
language:en
Short-container-title:Molecular Therapy - Nucleic Acids

Author:

Kostyushev Dmitry^ORCID,Kostyusheva Anastasiya,Brezgin Sergey,Ponomareva Natalia,Zakirova Natalia F.,Egorshina Aleksandra,Yanvarev Dmitry V.,Bayurova Ekaterina,Sudina Anna,Goptar Irina,Nikiforova Anastasiya,Dunaeva Elena,Lisitsa Tatiana,Abramov Ivan,Frolova Anastasiia,Lukashev Alexander,Gordeychuk Ilya,Zamyatnin Andrey A.,Ivanov Alexander,Chulanov Vladimir

Funder

Russian Science Foundation

Ministry of Science and Higher Education of the Russian Federation

Publisher

Elsevier BV

Subject

Drug Discovery,Molecular Medicine

Reference48 articles.

1. The molecular virology of hepatitis B virus;Glebe;Semin. Liver Dis.,2013

2. World Health Organization. Global Hepatitis Report, 2017; 2017. ISBN 978-92-4-156545-5.

3. The role of hepatitis B surface antigen quantification in predicting HBsAg loss and HBV relapse after discontinuation of lamivudine treatment;Chen;J. Hepatol.,2014

4. Persistence of cccDNA during the natural history of chronic hepatitis B and decline during adefovir dipivoxil therapy;Werle–Lapostolle;Gastroenterology,2004

5. A global scientific strategy to cure hepatitis B;Revill;Lancet Gastroenterol. Hepatol.,2019

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular epidemiology of hepatitis B virus (HBV) in Ethiopia: A review article;Infection, Genetics and Evolution;2024-08

2. Enzymatic Assembly for CRISPR Split-Cas9 System: The Emergence of a Sortase-based Split-Cas9 Technology;2024-02-29

3. Stochastic packaging of Cas proteins into exosomes;Молекулярная биология;2024-02-15

4. Stochastic Packaging of Cas Proteins into Exosomes;Molecular Biology;2024-02

5. CRISPR/Cas9 System with Dual gRNAs Synergically Inhibit Hepatitis B Virus Replication;Discovery Medicine;2024